András Zolnay

András Zolnay

Auto-generated profile, based on publicly available information

András Zolnay

Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2005
Verified
Conference Paper
Open access
SUS. Umesh
S. Umesh
AZAndrás Zolnay
András Zolnay
HNHermann Ney
Hermann Ney

1 September 2003
Verified
Conference Paper
Open access
AZAndras Zolnay
Andras Zolnay
RSRalf Schluter
Ralf Schluter
HNHermann Ney
Hermann Ney

12 November 2024 in Physics in Medicine & Biology
Verified
Journal Article
Open access
HNHazem A A Nomer
Hazem A A Nomer
FKFranziska Knuth
Franziska Knuth
JGJoep van Genderingen
Joep van Genderingen
DNDan Nguyen
Dan Nguyen
MSMargriet Sattler
Margriet Sattler
SBSebastiaan Breedveld
Sebastiaan Breedveld
Objective. Intensity modulated proton therapy (IMPT) is susceptible to uncertainties in patient setup and proton range. Robust optimization is employed in IMPT treatment planning to ensure sufficient coverage of the clinical target volume (CTV) in predefined scenarios, albeit at a price of increased planning times. We investigated a deep learning (DL) strategy for dose predictions in individual error scenarios in head and neck cancer IMPT treatment planning, enabling direct evaluation of plan robustness. The model is able to differentiate between scenarios by using embeddings of the scenario index. Approach. To accommodate resolution disparities in planning CT-scans and accommodate the setup error scenarios, we introduced scenario-specific isocentric distance maps as inputs to the DL models. For 392 H&N cancer patients, high-quality 9-scenario ground truth (GT) robust plans were generated with wish-list driven fully automated multi-criteria optimization. The scenario index is converted to one-hot-vector that is used to derive the scenarios embeddings through the training of the DL model, aiding the model to predict a scenario specific dose distribution. Main results. The model achieved within 1%-point of agreement with the GT the predicted V 95 % of the voxelwise minimum dose for CTV Low and CTV High for 96% and 75% respectively of the test patients. Considering all robustness scenarios, median differences were 0.035%-point for CTV High V 95 % , 0.11%-point for CTV Low V 95 % , 0.29 GyE for parotids D mean , 0.7 GyE for submandibular glands D mean and 0.9 GyE for oral cavity D mean . Prediction of full 3D dose distributions for all scenarios took around 14 s. Significance. Predicting individual scenarios for robust proton therapy using DL dose prediction is feasible, enabling direct robustness evaluation of the predicted scenario doses.

29 September 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
SKS. Kuipers
S. Kuipers
ENE. Negenman
E. Negenman
JGJ. Godart
J. Godart
ACA. Corbeau
A. Corbeau
AZA.G. Zolnay
A.G. Zolnay
MHM.S. Hoogeman
M.S. Hoogeman